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CTM/00264/2013Polym Adv Technol. 2018;1–9.Infection is one of the major risk factors for the development of chronic wounds.
Antimicrobial wound dressing has been pointed out as a viable option for the preven-
tion and treatment of wound infections. Thus, we developed a composite material
based on cotton textile substrates functionalized with cyclodextrin‐hydroxypropyl
methyl cellulose‐based hydrogel. The composites' ability to encapsulate and release
gallic acid (antimicrobial phenolic acid) was evaluated, as well as their mechanical
properties and antimicrobial and anti‐inflammatory capacity. All composites were able
to retain gallic acid in their structure, with similar loading profile. The presence of gal-
lic acid on composites was confirmed by FTIR and TGA. Composites storage moduli
was reduced by the presence of gallic acid. The results suggest a straight relation
between the swelling ability and gallic acid drug delivery profile. The drug delivery
mechanism, of the developed composites, was mainly controlled by Fickian diffusion,
based on the experimental data fitting to the Peppas‐Sahlin model. Gallic acid antimi-
crobial and anti‐inflammatory properties were transferred to the composite materials.
According to the results, the developed composites can be applied on the prevention
or treatment of chronic wounds.
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Wound dressings' research has been set by the insights on wound
healing process and by patients' demands. Nowadays, the patients have
high expectations regarding the wound dressings. Theymust accelerate
cicatrization, with minimal pain and best cosmetic and functional
results.1,2 This is especially important in the case of chronic or
nonhealingwounds. Chronic wounds represent a silent epidemic affect-
ing a large fraction of theworld's population. They are a burgeoning cost
in the health care system, aggravated by demographic developments.3
Chronic wounds can be triggered by repeated ischemia‐reperfusion
injury, altered cellular and systemic response, tissue hypoxia, or micro-
organisms.4,5 Among these, microorganism colonization and posterior
infection are particularly significant, since virtually, all chronic wounds
became contaminated, delaying the healing, causing malodorous and
exudates.4 Thus, the elimination of clinically relevant infections is a pre-
requisite for efficient wound healing.6wileyonlinelibrary.com/jouThe most common treatment for infected chronic wounds is the
systemic administration of broad‐spectrum antibiotics.7 Their indis-
criminate use affects skin flora and induce multiresistant strains.8 Top-
ical treatment with antimicrobial agents has been pointed out as a
good alternative to antibiotic therapy. Topical delivery ensures antimi-
crobial agent release at the infection site, reducing the concentration
need to control the infection and, consequently, the systemic absorp-
tion and toxicity.4,9
Antimicrobial wound dressings have been often used to protect
the wound from new injury, dehydration, and microorganism deposi-
tion.2 Several materials (textiles, hydrogels, foams, and films) have
been developed to deliver antimicrobial agents to infected wounds.10
Although, they still show inadequate release profile, characterized
by an initial burst that leads to local toxicity owed high antimicrobial
concentration, followed by a prolonged release of antimicrobial
agent below required concentration, selecting the resistant
microorganisms.9© 2018 John Wiley & Sons, Ltd.rnal/pat 1
2 PINHO ET AL.In a previous work,11 our research group optimized the synthesis
of a composite wound dressing obtained through the combination of
cotton textile substrates and cyclodextrin‐hydroxypropyl methyl
cellulose‐based hydrogel. The developed composite should gather
the suitable properties of textiles wound dressing, mechanical stability
and biocompatibility, and the hydrogels drug delivery and surface
properties.7,11,12 In order to complement the previous work, compos-
ites' ability to encapsulate and release small antimicrobial molecules
was evaluated, as well as their mechanical properties. The composites'
antimicrobial and anti‐inflammatory activities were also assessed.2 | MATERIALS AND METHODS
2.1 | Materials
Gallic acid (3,4,5‐trihydroxybenzoic acid) was provided byMerck, and β‐
cyclodextrin (βCD, 1135 g mol−1) and 2‐hydroxypropyl‐β‐cyclodextrin
(HPβCD, 1309 gmol−1) were acquired from AppliChem. Hydroxypropyl
methylcellulose (HPMC) Methocel K4 M (84 200 g mol−1; normal vis-
cosity, 400 mPa s) was purchased from VWR Prolab; 1,4‐butanediol
diglycidyl ether (BDGE, 50%‐60% v/v) was obtained from Acros
Organics. Purified water, obtained by reverse osmosis (MiliQ, Mikipore,
Madrid, Spain) with a resistivity above 18.2 MX cm, was used.
RAW264.7 cells were purchased from ECACC (European Colletion of
Authenticated Cell Culture, Salisbury, UK), lipopolysaccharide (LPS)
from Sigma, and DMEM medium from HyClone. The Griess Reagent
System Kit was purchased from Promega and dexamethasone from
Sigma. The textile substrates used were as follows: cotton (COT)
100% tubular mesh with 150 g m−2, washed according to ISO 105‐
C01, sterile nonwoven (NW) 100% cotton with 54 g m−2, and sterilized
gauze (GZ) 100% cotton with 24 g m−2.
2.2 | Composites synthesis
The optimal conditions to synthesize cotton‐hydrogel composites
were described in a previous work.11 The composites used in this
work were obtained by one‐step cross‐linking procedure. A polymeric
solution was prepared by dissolving the CDs (0.22 mol L−1 of βCD or
0.19 mol L−1 of HPβCD) and HPMC (5.95 × 10−5 mol L−1) in NaOH
(5 mL 0.2M). Then they were transferred to petri dishes, and the
cross‐linking agent (0.54 mol L−1 of BDGE) was added. After homoge-
nization, the textile subtracts (0.30 g of COT, NW, or GZ) were
immersed on the solutions. The cross‐linking procedure was per-
formed at 50°C for 20 hours. To remove the chemical residues, the
composites were washed with water (12 h), HCl (10mM) for an addi-
tional 12 hours, and kept in water for 7 days, at 25± 1°C. After, they
were dried at 40 ± 1°C for 24 hours and stored in a desiccator.
2.3 | Gallic acid encapsulation and release
Gallic acid solution (2.3 × 10−2 mol L−1, in methanol 2% v/v) was dis-
solved in H3PO4/NaOH buffer (pH 3 ± 0.5).
13 Dry composite samples
(30 ± 3 mg) were immersed in 5 mL of gallic acid solution at 25± 1°C
and 60 rpm. The amount of phenolic acid in the solution was assessedby UV‐vis spectrophotometry, until the absorbance values stabilize.
The gallic acid loading was calculated based on the variation of gallic
acid in the initial solution and at the equilibrium.
The gallic acid release, from composites, was performed using
load dry samples. The samples (30 ± 3 mg) were immersed in 5 mL
of synthetic sweat solution (SSS, 0.5 g of l‐histidine
monohydrochloride monohydrate, 5 g of sodium chloride, and 2.2 g
of sodium dihydrogen orthophosphate dihydrate, pH 5 ± 0.5). The
samples were maintained at 25± 1°C, and the absorbance of the
released medium was monitored until stabilization. A comparison of
goodness‐of‐fit to the Peppas‐Sahlin model was carried out by fitting
the model to the experimental data. Optimal parameters were found
through the software DDSolver.14
In both cases, loading and release, the absorbance was measured
at the gallic acid λmax (259 nm for pH 3, ε 2.30 M cm
−1 or 261 nm for
pH 5, ε 4.27 M cm−1). The gallic acid concentration was calculated
based on the calibration curve, previously determined. All the absorp-
tion measurements were recorded on a Jasco V560 spectrometer,
using a 1‐cm quartz cuvette.2.4 | Physic‐chemical characterization
Fourier transform infrared spectroscopy (FTIR‐ATR) spectrums were
obtained by analyzing samples (0.5 ± 0.05 g) of each composite with
or without gallic acid, COT‐βCD‐HPMC, NW‐βCD‐HPMC, GZ‐βCD‐
HPMC, COT‐HPβCD‐HPMC, NW‐HPβCD‐HPMC, and GZ‐HPβCD‐
HPMC. The spectra were recorded between 400 and 4000 cm−1, in
FTIR Shimadzu IRAffinity.
The thermal properties of the developed composites were charac-
terized by differential scanning calorimetry (DSC) and
thermogravimetry (TGA). DSC measurements were carried in liquid
nitrogen atmosphere using DSC‐822e instrument (Mettler Toledo).
The calibration was made with indium as standard. Samples were
weighed (2.5 ± 0.2 mg) and sealed in aluminum pans. Then they were
heated from 25°C to 350°C, at a scanning rate of 10°C min−1. Data
were treated using LAB Mettler star SW 8.1 software (Mettler‐Toledo
International Inc, Swiss). Composite samples' thermal behavior was,
also, investigated employing the simultaneous thermogravimetry–
differential scanning calorimetry (TG‐DSC) technique using a TA
Instruments model Hitachi STA7200. The samples (mass approx.
10 mg) were heated (20°C to 600°C) in a standard alumina sample
pan. All experiments were performed under dynamic nitrogen at a
flow rate of 0.1 dm3 min−1 using a heating rate of 10°C min−1 per
run. Degradation onset temperature was assigned at the temperature
at which 90% mass remained.2.5 | Mechanical properties
Strain‐to‐break tensile testing was performed using the tensile film
geometry on a TA Instruments Hitachi DMA7100. Samples were cut
into rectangular cuboids, measured, and clamped to the DMA geome-
try. A controlled extension force of 5 N min−1 was applied to the sam-
ple until the sample broke or the instrument reached maximal
PINHO ET AL. 3extension; experiments were conducted at room temperature. At least
three replicate measurements of each samples were conducted.2.6 | Composites biological properties assessment
2.6.1 | Antimicrobial properties
The composites' antibacterial activity was tested against two bacteria:
Staphylococcus aureus (ATCC 6538) and Escherichia coli (ATCC 25992).
The absorption method described in JIS L 1902:2008 was used, with
the following alterations.15 An inoculum was prepared in
20.0 ± 0.1 mL of TSB (Tryptic Soy Broth, Merck) and incubated for a
period of 18 hours at 37 ± 1°C under agitation (120 rpm). Subse-
quently, the bacterial concentration was adjusted to 3 × 108 cells mL
−1 via absorbance readings and based on a corresponding calibration
curve. An aliquot of the above suspension (400 μL) was added to
20 mL of TSB and incubated for 3.0 hours at 37 ± 1°C. The bacterial
concentration was again measured, and 3 × 105 cells mL−1 were
obtained using a 20‐fold dilution of TSB (in distilled water). The
50 μL of this inoculum was then added to each sample (1 ± 0.01 g).
Samples were incubated for 8 or 24 hours at 37 ± 1°C. Subsequently,
5 mL of physiological saline solution (8.5 g of NaCl and 2.0 g of non-
ionic surfactant Tween 20 [Sigma Chemical Co] per litter) were added
to the samples, which were then vortexed five times for 5 seconds.
The number of living bacteria was assessed by the serial dilution plate
count method. All assays were performed in triplicate and repeated
three times.2.6.2 | Anti‐inflammatory properties
The anti‐inflammatory properties of the developed composites was
evaluated in vitro, using the murine macrophage (RAW 264.7) cell line,
according to the method previously described by Sobral and
coworkers.16 The cells were cultured in DMEMmedium and incubated
at 37 ± 1°C under 5% CO2, in humidified air. For each experiment,
cells were detached with a cell scraper and seeded at 1.5 × 105 cells
per well in a 96‐well plate. The plate was incubated overnight to allow
their attachment. The samples were kept in DMEM for 24 hours. Then
the extracted solution of the samples was added to each well, and
plate was incubated for 1 hour. The following step was stimulation
with LPS (1 μg mL−1) for 24 hours. The effect of all tested samples
in the absence of LPS was also evaluated. The cells were incubated
again for 24 h. A Griess Reagent System Kit was used to nitric oxide
(NO) determination, which contains sulfanilamide, N‐1‐
naphthylethylenediamine dihydrochloride (NED), and nitrite solutions.
The cell culture supernatant (100 mL) was transferred to the plate, in
duplicate, and mixed with sulfanilamide and NED solutions. The nitrite
produced was determined by measuring the optical density at 540 nm,
in the microplate reader, and was compared with the standard calibra-
tion curve (y = 0.0063x + 0.1262, R2 = 0.9994). The results were
expressed in percentages of inhibition of NO production in compari-
son with the negative control (100%). Dexamethasone (Sigma‐Aldrich,
St Louis, MO, USA was used as positive control
(IC50 = 15.69 ± 1.35 μg/mL).All procedures were performed in triplicate. An analysis of vari-
ance (ANOVA) was carried out to determine any significant differ-
ences between the standard conditions and the new adaptations.
The data were processed with the GraphPad Prism program for Win-
dows, version 7.3 | RESULTS AND DISCUSSION
Nowadays, consumers are more aware of natural products and eco‐
friendly procedures' benefits. Products obtained from natural sources
are biocompatible and biodegradable, opposing to most synthetic
products. The search for goods with high biocompatibility and reduced
side‐effects is paramount for the wound dressing market.17-20 Thus,
we developed a composite wound dressing based on products from
natural sources, cotton, cyclodextrins, and cellulose. The cotton still
is a standard dressing for wound management, since it offers mechan-
ical support and gas and water permeability.21 Cellulose, as the main
component of cotton, is nontoxic, homeostatic, nonallergic, and bio-
compatible.22 Cyclodextrins are biocompatibility cyclic oligosaccha-
rides and approved by FDA.23 They are able to protect and
modulate the release of a wide range of molecules.23 An antimicrobial
agent, gallic acid, was also used in the present work to add the ability
to prevent and control infection to the composite. Gallic acid antimi-
crobial activity, biocompatibility, and incorporation on a cyclodextrin‐
cellulose–based hydrogel were already proved in other works.13,24-263.1 | Gallic acid loading
All the composites were able to retain gallic acid in their structure, with
similar loading profile. Gallic acid loading equilibrium was reached after
360minutes for the composites (COT‐HPMC‐CD, NW‐HPMC‐CD, and
GZ‐HPMC‐CD) and immediately for the nonfunctionalized textile
substrates (COT, NW, and GZ). The cyclodextrin used had the same
influence on the three substrates. The composites obtained with
HPMC‐HPβCD were able to retain more gallic acid than the ones with
HPMC‐βCD. These results are in accordance with the polymeric net-
works and composites swelling behavior. Since in previous works, it
was observed that the HPMC‐HPβCD composites could accommodate
more water molecules than HPMC‐βCD11 and gallic acid had more
affinity to form inclusion complexes with HPβCD, than with βCD.13,27
Regardless the cyclodextrin used, the GZ composites showed more
affinity to gallic acid (Figure 1). They retained 256 mg GA/g composite
(HPMC‐βCD) and 388 mg GA/g composite (HPMC‐HPβCD).
The hydrogel network assembled on the cotton fibers was the
manly responsible for the composite ability to retain gallic acid.
The loading profile was, also, influenced by the cross‐linking degree
of the polymeric network, cyclodextrins available to form inclusion
complex with the phenolic compound, and gallic acid affinity to all net-
work compounds.11
3.1.1 | Physic‐chemical characterization
Figure 2 shows the FTIR spectrum of the composites with or without
gallic acid. The FTIR spectrums of the composites COT‐HPMC‐CD,
FIGURE 1 Gallic acid loading in COT, NW, or GZ (white), composites
with HPMC‐βCD (grey), and composites with HPMC‐HPβCD (black).
The loading was performed during 24 hours, 25 ± 1°C with gallic acid
dissolved on the buffer H3PO4/NaOH (pH 3 ± 0.5, 2% v/v MeOH). All
data are expressed as mean and standard deviation (n = 3). Statistically
different from COT/NW or GZ, *P < 0.001 and **P < 0.0001
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4 PINHO ET AL.NW‐HPMC‐CD, and GZ‐HPMC‐CD were analyzed in the first part of
this work.11 On gallic acid FTIR spectrum (Figure 2, black), there is a
broad peak from the aromatic and carboxylic O―H stretching at
3483 and 3256 cm−1. At 2924 cm−1 was identified the peak corre-
spondent to hydrogens bonds stretching between the phenolic
groups. The intense peaks at 1659 and 1605 cm−1 result from the con-
jugate acids C―O stretching. The combination of OCC asymmetric
stretching and OH bend is observed through to the peaks at 1425
and 1264 cm−1. The aromatic ring stretching is detected at 1432 cm
−1, and the CO stretching is displayed at 1218 cm−1. The peaks
observed at 1029 cm−1 result from the out‐of‐plane aromatic bend-
ing.28,29 The composites with gallic acid had similar profiles to the
materials without gallic acid. However, they display the appearance
of two peaks at 1659 and 1605 cm−1, identified as C―O stretching
from the gallic acid conjugate acids, confirming the presence of gallic
acid on the composite materials.
Figure 3 (black) displays the gallic acid DSC spectrum. Since the
phenolic acid is a pure substance, only an endothermic sharp peak
was observed. The gallic acid did not induce any changes on the
composites' thermal properties detected by DSC. All compositesshowed two endothermic peaks associated with the water lose
(between 100°C and 150°C) and the cyclodextrins degradations near
300°C.11
Therefore, composites were subject to TGA analysis to evaluate
their weight change with the temperature increase. From Figure 4 and
Table 1, it is possible to observe that the presence of gallic acid
induced changes on composites thermal behavior, detected by TGA.
Regardless the cyclodextrin or textile substrate used, the gallic acid
decreased the degradation temperature (Tg). Gallic acid maximum
weight lost temperature occur near 275°C, as consequence of it
crystalline melting.30 Hence, the composites with gallic acid Tg incre-
ment confirms the presence of gallic acid on the network. Gallic acid
presence was, also, proved by the weight loss. The remaining weight
percentage after decomposition was superior for the composites with
gallic acid. Similar effect on the thermal behavior of fibers loaded with
gallic acid was described by Neo and coworkers.30 They found that
gallic acid shifts the loaded fibers Tg to a lower temperature, when
compared with the pure gallic acid as result of a change on the pheno-
lic compound physical state.303.2 | Composites' mechanical properties
Even though hydrogels gather suitable properties for wound treat-
ment, they lack mechanical stability, reducing their performance on
the wound site.31 Considering this drawback, the mechanical stiffness
of the developed composites was assessed by DMA (Table 2).
The storage moduli (E′) represents the stiffness of a viscoelastic
material and is proportional to the energy stored during a loading
cycle.32 Table 2 lists the E′ of the controls (COT, NW, and GZ) and
composites with and without gallic acid at 25 ± 1°C (storage temper-
ature) and 36± 1°C (end‐use temperature). The temperature had no
effect on the textile subtracts' stiffness. However, the increase of tem-
perature reduced the stiffness of the composites. The gallic acid
encapsulation, also, reduced the E′ of the composites.3.3 | In vitro gallic acid release
Composites ability to release gallic acid was assessed using a synthetic
sweat solution, to mimic the conditions found on the skin surface. AllFIGURE 2 FTIR spectra gallic acid (black),
COT‐HPMC‐CD (light blue), COT‐HPMC‐CD/
GA (dark blue), NW‐HPMC‐CD (light green),
NW‐HPMC‐CD/GA (dark green), GZ‐HPMC‐
CD (light orange), and GZ‐HPMC‐CD/GA
(dark orange), with (A) βCD or (B) HPβCD
[Colour figure can be viewed at
wileyonlinelibrary.com]
FIGURE 3 DSC spectra gallic acid (black),
COT‐HPMC‐CD (light blue), COT‐HPMC‐CD/
GA (dark blue), NW‐HPMC‐CD (light green),
NW‐HPMC‐CD/GA (dark green), GZ‐HPMC‐
CD (light orange), and GZ‐HPMC‐CD/GA
(dark orange), with (A) βCD or (B) HPβCD
[Colour figure can be viewed at
wileyonlinelibrary.com]
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FIGURE 4 TGA spectra textile subtract
(black; A and B, COT; C and D, NW; E and F,
GZ), COT‐HPMC‐CD (light blue), COT‐
HPMC‐CD/GA (dark blue), NW‐HPMC‐CD
(light green), NW‐HPMC‐CD/GA (dark green),
GZ‐HPMC‐CD (light orange), and GZ‐HPMC‐
CD/GA (dark orange), with (A, C, D) βCD or (B,
D, F) HPβCD [Colour figure can be viewed at
wileyonlinelibrary.com]
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TABLE 1 TGA values of the composite materials with or without gallic acid
COT NW GZ
Tp, °C G, % Tp, °C Tp, °C Tp, °C G, %
HPMC‐βCD 372 13.26 376 10.06 380 12.81
HPMC‐βCD/GA 344 17.76 364 13.65 370 15.29
HPMC‐HPβCD 376 13.67 373 9.31 361 12.80
HPMC‐HPβCD/GA 338 15.88 362 18.30 320 18.27
PINHO ET AL. 5composites were capable of sustaining the gallic acid release for
48 hours. It was observed a faster release during the first 360 minutes,
followed by a plateau until 48 hours. The phenolic acid migration from
the composite surface to the solution was responsible for the initial
burst. The slower release, overserved after 6 hours, was aconsequence of the inclusion complexes gallic acid‐cyclodextrin
dissociation.24
The gallic acid quantity released from composites (Figure 5) was in
accordance with the loading results (Figure 1). The textile substrate
released almost all the gallic acid loaded (COT 71%, NW 71%, and
TABLE 2 Storage moduli (E′) of the composites with and without gallic acid, at 25 ± 1°C and 36± 1°C
E′ (108 Pa)
COT NW GZ
25°C 36°C 25°C 36°C 25°C 36°C
Control 0.61 0.66 0.94 1.11 0.41 0.56
HPMC‐βCD 0.55 0.27 6.05 4.06 7.48 4.88
HPMC‐βCD/GA 0.21 0.12 2.17 1.23 5.96 2.70
HPMC‐HPβCD 2.41 1.19 1.80 1.50 2.20 1.45
HPMC‐HPβCD/GA 0.25 0.29 0.95 0.21 0.47 0.30
FIGURE 5 Gallic acid release from COT, NW, or GZ (white),
composites with HPMC‐βCD (grey), and composites with HPMC‐
HPβCD (black). It was performed during 48 hours, 37 ± 1°C within
synthetic sweat solution (pH 5 ± 0.1). All data are expressed as mean
and standard deviation (n = 3). Statistically different from COT/NW or
GZ, *P < 0.001 and **P < 0.0001
6 PINHO ET AL.GZ 72% w/w). The composites functionalized with HPMC‐βCD or
HPMC‐HPβCD released 39% and 64% (w/w) of the gallic acid retained
on the network.
Composites drug delivery capacity is highly dependent on the
hydrogel network swelling and release properties. Thus, their drug
delivery capacity is set by the following process: solvent transport into
the polymeric matrix, polymer swelling, solute diffusion, and
erosion/relaxation of the swollen polymer.33-35 Furthermore, previous
studies had proven that the use of cyclodextrins on the polymeric
hydrogel benefits their drug delivery properties.33,36,37
In this case, the inclusion complex strength, between the cyclo-
dextrins and gallic acid, had a major influence on the drug delivery
capacity of the composites. The inclusion complexes HPβCD‐gallic
acid are more stable than the ones obtained with βCD.13,24 Therefore,
despite HPMC‐HPβCD composites accommodating more gallic acid,
the amount released was similar to HPMC‐βCD composites.TABLE 3 Composites' kinetics release parameters using Peppas and Sah
Control HPMC‐βCD
r2 kD kR r
2 kD
COT 0.89 ± 0.07 10.22 ± 0.06 −1.53 ± 0.05 0.94 ± 0.05 29.25
NW 0.90 ± 0.02 16.84 ± 058 −2.03 ± 0.05 0.90 ± 0.03 19.66
GZ 0.96 ± 0.03 41.15 ± 0.03 −6.29 ± 0.43 0.91 ± 0.03 42.24For a more comprehensive characterization of the release profiles,
the data were analyzed by fitting to Peppas‐Sahlin model (Equation 1),
since it have been successfully applied to HPMC and cyclodextrin
based hydrogel drug delivery systems.33-35,38 This release kinetics
model considers the diffusional and relaxational mechanism associated
with the anomalous drug released process of hydrogels.39 Considering
the right side of Equation 1, the first term calculates the molecular dif-
fusion of the drug as consequence of the chemical potential gradient,
Fickian contribution (F). The second term represents the Case II relax-
ation contribution (R), set by the stress and state‐transition of
swelling‐controlled drug release.34,40
Mt
M∞
¼ kDtm þ kRt2m; (1)
where Mt and M∞ are the absolute cumulative amount of drug
released at time (t, minute) and infinite time and kD (diffusional con-
stant), kR, and m are constants.
41
A good fitting was observed between the experimental data and
the Peppas‐Sahlin model, since the r2 values were superior to 0.90
for all the composites (Table 3). Moreover, kD values were always
superior to kR, meaning that the drug release mechanics of the com-
posites was control by Fickian diffusion.42 The functionalization with
hydrogels significantly influence the release profiles of the textiles
substrates, improving it. The diffusional constants obtained were
superior for the composites, comparative with the control substrates,
regardless the cyclodextrins used. The predominance of Fickian diffu-
sion as drug delivery mechanism on cyclodextrin‐based hydrogels was
also described in several works.33,43,44
The same behavior was, also, observed on composites obtained
by the conjugation of hydrogel networks and textile substrates. For
instance, Cirillo and coworkers45 developed a cotton‐gauze‐hydrogel
composite electroresponsive drug delivery system to be used as
wound dressing. By fitting the experimental data to the Peppas‐Sahlin
model, they conclude that the release rate was faster when high volt-
ages were applied and Fickian diffusion was the prevalent mechanism
of drug delivery.45lin model (Equation 1)
HPMC‐HPβCD
kR r
2 kD kR
± 0.73 −2.85 ± 0.09 0.95 ± 0.03 16.21 ± 0.27 −0.66 ± 0.08
± 0.28 −3.41 ± 0.07 0.90 ± 0.03 55.33 ± 0.03 −3.41 ± 0.07
± 0.39 −3.50 ± 0.07 0.90 ± 0.03 40.49 ± 0.48 −2.40 ± 0.58
PINHO ET AL. 73.4 | Composites biological properties
3.4.1 | Antimicrobial capacity
The presence of microorganism on the wound bed may delay the
healing process, giving rise to chronic wounds. Gallic acid is a simple
phenolic acid with good applicability as antibacterial agent against
bacteria, commonly isolated from infected wounds.46 It was, already
used, with success to add antimicrobial properties to hydrogels
networks.24,28,47 Thus, the antimicrobial activity of the developed
composites was investigated (Figure 6). The textiles substrates (COT,
NW, or GZ), the functionalized substrates with HPMC‐βCD, or
HPMC‐HPβCD prevented the bacteria growth. Otherwise, the
composite materials loaded with gallic acid destroyed all bacteria,
independently the contact time. According to the results obtained, it
was verified that the gallic acid's antibacterial activity was preserved
after incorporation within the composite material.
Even though natural antimicrobial agents have been described as
a viable alternative to antibiotics on the chronic wound treatment, just
a few paper are available reporting the use of antimicrobial agents to
functionalize cotton‐hydrogel composites. Nevertheless, they support
the above results regarding the maintenance of the natural agents'
antimicrobial activity after their encapsulation by textile‐hydrogel
composites.48,49 For instance, Xu and coworkers were able to incorpo-
rate a berberine nanosuspension in a poly(N‐isopropylacrylamide)/algi-
nate copolymer hydrogel‐grafted fabrics. Based on their results, the
developed composite was able to sustain the release of berberine,
and it kept their biological properties (antimicrobial effect, promotion
of granulation and capillary formation, wound closure, moisture regu-
lation, and hemostasis).48 Similar results were described using a cotton
fabric modified with a chitosan‐poly(N‐isopropylacrylamide) interpen-
etrating polymer network hydrogel.49 The chitosan antimicrobial activ-
ity was present on the cotton modified fabric, as well as the
thermosensitive behavior of the hydrogel network.49FIGURE 7 Composites' anti‐inflammatory activity by quantification
of the NO (nitric oxide) inhibition production percentage. COT, NW,
or GZ (black), composites functionalized with HPMC‐βCD (fill dark
grey), HPMC‐βCD/GA (no fill dark grey), and composites with HPMC‐
HPβCD (fill light grey) and HPMC‐HPβCD/GA (no fill light grey)3.4.2 | Anti‐inflammatory properties
Chronic wounds result from a breakdown on the healing process,
caused by prolonged inflammation stage. Infection has been
described as the major cause of chronic wounds, specially the pres-
ence of biofilms. The persistent of infection stimulate the constant
influx of immune cells, extending the proinflammatory cytokine cas-
cade and rise the proteases concentration on the wound bed. TheFIGURE 6 Quantitative analysis of
antibacterial activity of the gallic acid loaded
composites by direct contact, for 8 or
24 hours, against (A) Staphylococcus aureus
and (B) Escherichia coli, 5 × 105 cells mL−1.
■COT‐βCD, ■NW‐βCD, ■GZ‐βCD, □COT‐
HPβCD, □NW‐HPβCD, □GZ‐HPβCD;
■COT‐βCD/GA,■NW‐βCD/GA,■GZ‐βCD/
GA, □COT‐HPβCD/GA, □NW‐HPβCD/GA,
and □GZ‐HPβCD/GA [Colour figure can be
viewed at wileyonlinelibrary.com]inhibition of protease fails, leading to the destruction of the extracel-
lular matrix and growth factors, as well as their receptors. This pre-
vents the wound from moving forward to the proliferative phase
and attracts more inflammatory cells, intensifying the inflammatory
cycle.3,50-52
The production reactive nitrogen species is a consequence of the
inducible nitric oxide synthase (iNOS) activity, an inflammatory media-
tor. NO (nitric oxide) has been described as an important mediator of
acute and chronic inflammation.53 Thus, NO has been used as param-
eter to assess in vitro the anti‐inflammatory capacity of molecules and
materials.54
Therefore, the anti‐inflammatory properties of the developed
composites were assessed by the quantification of (NO) production
inhibition. The loaded composites (HPMC‐βCD/GA and HPMC‐
HPβCD/GA), regardless the subtracted used, were able to prevent
60% of the NO production by the cells RAW 264.7 (Figure 7). Other-
wise, the controls and composites without GA, only, prevent between
10% and 30% of the NO production.
Gallic acid, besides its antimicrobial activity, has been described as
a strong anti‐inflammatory agent.23,55 A direct relation between the
concentration of gallic acid and the inhibition of NO production in
LPS/IFN‐γ‐activated macrophages was, also, demonstrated by Wang
and coworkers.56 Accordingly, gallic acid was able to migrate from
the cyclodextrins cavity and hydrogel network to the medium, without
losing biological properties, based on the obtained results.C
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In a previous work, the synthesis optimization and physicochemical
characterization of composite wound dressings obtained by the
cross‐linking between cotton textile substrates and cyclodextrin‐
cellulose based hydrogels were performed. It was proved that the
functionalization of the textile substrates improved their applicability
as wound dressing.
Regarding the present work, encapsulation of antimicrobial gallic
acid by the developed materials gave rise to a composite wound dress-
ing with enhanced biological properties. Gallic acid was successfully
loaded into the composite materials, and its presence was proven by
FTIR and TGA composite profiles. The phenolic acid release was
improved by the presence of cyclodextrins and was mainly driven by
Fickian diffusion. The antimicrobial and anti‐inflammatory properties
of gallic acid were not compromised after its incorporation on the
composites network.
Thus, it is possible to synthetize composite wound dressings using
natural compounds and eco‐friendly procedures and transfer the anti-
microbial and anti‐inflammatory properties gallic acid to it. This work
presents a valuable route towards the functionalization of cotton
improving its application as wound dressing.
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